This system provides us with a real-time, clear view of the medical cannabis in Virginia. “We can track the growth of plants, see what products are most popular and analyze sales trends.”
By Markus Schmidt, Virginia Mercury
Virginia’s seed-to sale tracking system, which has been in operation for only two months, is already providing the most comprehensive picture of its medical cannabis market. Data released last week confirms this.
Operated by the Virginia Cannabis Control Authority (CCA) and run through the private vendor Metrc, the system monitors every plant, product and sale in real time—a first for the commonwealth. The platform recorded 17,786 harvested plants, almost $30 million in sales, and over 256,000 transactions between July and August.
Jamie Patten said, “This system allows us to have a real-time, clear view of all medical marijuana in Virginia.” Jamie Patten is the acting chief administrative officer and head of CCA. We can track the growth of plants, identify sales trends, and see what products are most popular. The information we collect helps us prevent illegal products entering the marketplace, protect our patients, and plan for the future.
Early data from the tracking system gives a good idea of what is being purchased by patients. The majority of the sales came from cannabis buds (flower), while concentrates accounted for 32% of the purchases. Infused edibles accounted for 15 percent, and shake trim—the loose leaf material left after flower processing—represented 5 percent.
These insights, say state regulators, can improve transparency and guide the oversight of a program which has been plagued by complaints. The Metrc platform is required for licensed processors, according to officials, as it ensures that consumers only receive cannabis which has been tested and regulated.
CCA will build upon the launch by creating a dashboard that Virginians themselves can use to view sales and product data.
As patients raise questions about access and affordability, the numbers are increasing. A 2024 survey conducted by the Virginia Medical Cannabis Coalition found that a majority of patients felt prices were too high and options too limited. Many respondents said they traveled to Washington, D.C., and Maryland in order to get cheaper products.
In addition, feedback from the public collected last year by the state highlighted frustrations about wait times, variety of products and affordability. One patient told WVTF Public Radio they paid nearly twice as much in Virginia compared with neighboring states, while others described the program as confusing and overly restrictive.
CCA leaders said increased transparency and stricter oversight could help stabilise the market.
Virginia’s Medical Cannabis Program allows qualified patients to legally access state-regulated cannabis products, provided they receive a written certification from a licensed medical practitioner, such as a physician, physician assistant or advanced practice nurse.
Residents of Virginia must have at least the age of 18 and a health condition their physician believes could be improved by cannabis use. Parents or legal guardians may certify minors.
Once they have the certification, they may purchase medical cannabis from licensed dispensaries; the law no longer requires patients to register with the state Board of Pharmacy in order to access the program—a change that took effect in July 2022.
The certificate must be renewed every year unless the doctor specifies otherwise. Under the supervision of the CCA, all the medical cannabis sold through the program comes from state-licensed producers, is tested, regulated and monitored to ensure its safety and legality.
The unveiling of the CCA’s seed-to-sale system also comes against the backdrop of a broader debate at the General Assembly—whether to allow recreational cannabis sales. The lawmakers legalized the simple possession of cannabis in 2021, but they never created a retail market. Medical cannabis is now the only option that consumers have.
This summer, a joint legislative commission heard multiple proposals outlining potential frameworks for recreational sales, including timelines, tax structures and licensing options. Virginians are likely to continue turning to illegal markets and dispensaries out of state if there is no legal retail system.
Though political differences remain, legislators are considering whether they should introduce a system of retail sales as soon as 2026.
The push follows the creation of a new Joint Cannabis Commission, which began meeting in July to study retail models and prepare legislation. The Metrc platform has strengthened Virginia’s Medical Cannabis System, according to advocates.
CCA is focusing on improving the medical program at this time and making sure the public’s safety. Seed-to-sale allows regulators track products through cultivation and distribution to reduce the risks of contamination or diversion.
The dashboard was not launched yet, according to officials. However, they said that it would provide patients and legislators with a better understanding of how the market functions.
Virginia Mercury was the first to publish this story.